Intel is ready to compete with its biggest rivals: Nvidia and AMD with its own graphic cards. The American chip maker is developing its own arc chemist lineup of advanced GPUs that will compete with Nvidia’s offerings such as the RTX 3070 Ti and 3060 Ti.
According to a new rumor from IT Home, Intel originally planned to launch its new GPUs in January 2022, but the plan has reportedly been postponed. GPUs are now expected to launch by the end of Q1 and may slip by Q2, but it remains to be seen whether Intel intends to delay further.
The report states that the first batch of Arc Alchemist cards based on Xe-HPG DG2 GPUs has already been sent to Intel’s AIB partners for debugging. This means that we can expect a large number of GPUs available at launch with the reference model.
In addition to the entry-level ARC A380 Graphic card, the lineup will feature two other models that will compete with Nvidia and AMD’s top offerings. The top-end Chemist 512 EU with 32 Xe Core will have at least three configurations. Here are the expected specifications for each:
- 512 EU (4096 ALUs) / 16 GB @ Up To 18 Gbps / 256-bit / 225W (Desktops) & 120-150W (Laptops)
- 384 EU (3072 ALUs) / 12 GB @ Up To 16 Gbps / 192-bit / 150-200W (Desktops) & 80-120W (Laptops)
- 256 EU (2048 ALUs) / 8 GB @ Up To 16 Gbps / 128-bit / 60-80W (Laptops)